Contemporary Management of HIV: Managing HIV in Viral Hepatitis Coinfection
Source: Contemporary Management of HIV

Slideset

Contemporary Management of HIV: Managing HIV in Viral Hepatitis Coinfection

In this downloadable slideset, David L. Wyles, MD, and Program Director Eric S. Daar, MD, review key data and optimal approaches for ART management in patients with HIV and viral hepatitis coinfection.
Format: Microsoft PowerPoint (.ppt)
File size: 755 KB
Date posted: 1/20/2017
  • Adherence Concerns: Are We Limited to Boosted PIs?

    Joseph J. Eron, Jr. MD - 8/24/2015    3 comments / Last Comment: 9/3/2015
    My take on why an integrase inhibitor–based regimen makes sense for an ART-naive patient who struggles with adherence to care and medications.
  • ART in Older Patients: How I Manage Drug–Drug Interactions With Concomitant Medications

    Anton L. Pozniak MD, FRCP - 10/20/2015    16 comments / Last Comment: 5/10/2016
    As our patients age, they experience metabolic changes and more frequently develop conditions such as bone mineral density loss, cardiovascular disease, diabetes, and malignancies, all of which will affect the choice of first-line ART.
  • How I Approach Patients Who Are Reluctant to Initiate ART

    Daniel R. Kuritzkes MD - 9/8/2015    5 comments / Last Comment: 9/24/2016
    In this patient case example, I review how I counsel patients who are hesitant to begin first-line ART.
  • Why ART Trials Specific to Women Are Important

    Kathleen E. Squires MD - 9/28/2016    2 comments / Last Comment: 10/19/2016
    Although almost one half of new HIV infections worldwide occur in women, to date, clinical trials for FDA-approved ART regimens have largely been conducted in men. Here is my take on why women-specific ART trials are important.
  • My Approach to First-line ART for Patients With High Cardiovascular Disease Risk

    William G. Powderly MD - 10/6/2015    4 comments / Last Comment: 11/8/2015
    When treating HIV in patients with risk factors for CVD, selecting the optimal ART regimen is only part of the equation.